Spruce Biosciences (SPRB) Shares Issued (2019 - 2025)
Spruce Biosciences (SPRB) posted quarterly Shares Issued of $12531.0 for Q4 2025, down 72.83% year-over-year from $46122.0 in Q4 2024, and down 72.83% quarter-over-quarter from $46122.0 in Q4 2024.
Spruce Biosciences (SPRB) Shares Issued (2019 - 2025) Analysis & Trends
Spruce Biosciences (SPRB) has reported Shares Issued for 7 consecutive years, with $12531.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued fell 72.83% year-over-year to $12531.0; the TTM figure through Dec 2025 stood at $12531.0 (down 72.83% YoY), while the FY2025 annual figure was $12531.0, down 72.83% from the prior year.
- Shares Issued retreated to $12531.0 in Q4 2025 per SPRB's latest filing, from $46122.0 in the prior quarter.
- Across five years, Shares Issued topped out at $4.2 million in Q3 2022 and bottomed at $12531.0 in Q4 2025.
- Historically, Shares Issued has averaged $2.3 million across 5 years, with a median of $2.5 million in 2021.
- Annual changes were most pronounced in 2021 — Shares Issued soared 359.82% — and 2024, when it plunged 98.87%.
- Spruce Biosciences' Shares Issued stood at $2.2 million in 2021, then surged by 88.01% to $4.2 million in 2022, then decreased by 1.65% to $4.1 million in 2023, then slumped by 98.87% to $46122.0 in 2024, then slumped by 72.83% to $12531.0 in 2025.
- Business Quant data shows SPRB's Shares Issued at $12531.0 in Q4 2025, $46122.0 in Q4 2024, and $4.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Spruce Biosciences | 123.98 Mn | 123.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,531.00 |
| Dec 31, 2025 | 12,531.00 |
| Dec 31, 2024 | 46,122.00 |
| Dec 31, 2024 | 46,122.00 |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Sep 30, 2021 | 2.51 Mn |
| Sep 30, 2021 | 2.51 Mn |
| Jun 30, 2021 | 2.61 Mn |
| Jun 30, 2021 | 2.61 Mn |